AAAAAA

   
Results: 1-16 |
Results: 16
Biotherapeutic agents in the treatment of infectious diarrhea
Authors: Elmer, GW McFarland, LV
Citation: Gw. Elmer et Lv. Mcfarland, Biotherapeutic agents in the treatment of infectious diarrhea, GASTRO CLIN, 30(3), 2001, pp. 837
The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii
Authors: Surawicz, CM McFarland, LV Greenberg, RN Rubin, M Fekety, R Mulligan, ME Garcia, RJ Brandmarker, S Bowen, K Borjal, D Elmer, GW
Citation: Cm. Surawicz et al., The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii, CLIN INF D, 31(4), 2000, pp. 1012-1017
Beneficial microbes: health or hazard?
Authors: McFarland, LV
Citation: Lv. Mcfarland, Beneficial microbes: health or hazard?, EUR J GASTR, 12(10), 2000, pp. 1069-1071
Pediatric Clostridium difficile: A phantom menace or clinical reality?
Authors: McFarland, LV Brandmarker, SA Guandalini, S
Citation: Lv. Mcfarland et al., Pediatric Clostridium difficile: A phantom menace or clinical reality?, J PED GASTR, 31(3), 2000, pp. 220-231
Dietary fiber affects the onset of Clostridium difficile disease in hamsters
Authors: Horner, KL LeBoeuf, RC McFarland, LV Elmer, GW
Citation: Kl. Horner et al., Dietary fiber affects the onset of Clostridium difficile disease in hamsters, NUTR RES, 20(8), 2000, pp. 1103-1112
Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting
Authors: Levy, DG Stergachis, A McFarland, LV Van Vorst, K Graham, DJ Johnson, ES Park, BJ Shatin, D Clouse, JC Elmer, GW
Citation: Dg. Levy et al., Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting, CLIN THER, 22(1), 2000, pp. 91-102
Re: Probiotics and C-difficile diarrhea
Authors: McFarland, LV
Citation: Lv. Mcfarland, Re: Probiotics and C-difficile diarrhea, AM J GASTRO, 95(8), 2000, pp. 2128-2128
Recurrent Clostridium difficile disease: Epidemiology and clinical characteristics
Authors: McFarland, LV Surawicz, CM Rubin, M Fekety, R Elmer, GW Greenberg, RN
Citation: Lv. Mcfarland et al., Recurrent Clostridium difficile disease: Epidemiology and clinical characteristics, INFECT CONT, 20(1), 1999, pp. 43-50
Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients
Authors: Elmer, GW McFarland, LV Surawicz, CM Danko, L Greenberg, RN
Citation: Gw. Elmer et al., Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients, ALIM PHARM, 13(12), 1999, pp. 1663-1668
Possible role of cross-transmission between neonates and mothers with recurrent Clostridium difficile infections
Authors: McFarland, LV Surawicz, CM Greenberg, RN Bowen, KE Melcher, SA Mulligan, ME
Citation: Lv. Mcfarland et al., Possible role of cross-transmission between neonates and mothers with recurrent Clostridium difficile infections, AM J INFECT, 27(3), 1999, pp. 301-303
Pseudomembranous colitis: Causes and cures
Authors: Surawicz, CM McFarland, LV
Citation: Cm. Surawicz et Lv. Mcfarland, Pseudomembranous colitis: Causes and cures, DIGESTION, 60(2), 1999, pp. 91-100
Quality control and regulatory issues for biotherapeutic agents
Authors: McFarland, LV
Citation: Lv. Mcfarland, Quality control and regulatory issues for biotherapeutic agents, BIOTHERAPEUTIC AGENTS AND INFECTIOUS DISEASES, 1999, pp. 1-26
Biotherapeutic agents for Clostridium difficile-associated disease
Authors: McFarland, LV
Citation: Lv. Mcfarland, Biotherapeutic agents for Clostridium difficile-associated disease, BIOTHERAPEUTIC AGENTS AND INFECTIOUS DISEASES, 1999, pp. 159-193
Risks of biotherapeutic agents
Authors: Surawicz, CM McFarland, LV
Citation: Cm. Surawicz et Lv. Mcfarland, Risks of biotherapeutic agents, BIOTHERAPEUTIC AGENTS AND INFECTIOUS DISEASES, 1999, pp. 263-268
Epidemiology, risk factors and treatments for antibiotic-associated diarrhea
Authors: McFarland, LV
Citation: Lv. Mcfarland, Epidemiology, risk factors and treatments for antibiotic-associated diarrhea, DIGEST DIS, 16(5), 1998, pp. 292-307
Comment on 'the lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients'
Authors: Elmer, GW McFarland, LV
Citation: Gw. Elmer et Lv. Mcfarland, Comment on 'the lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients', J INFECTION, 37(3), 1998, pp. 307-308
Risultati: 1-16 |